Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase
about
Structures of Cryptococcus neoformans Protein Farnesyltransferase Reveal Strategies for Developing Inhibitors That Target Fungal PathogensCrystal structures of the fungal pathogenAspergillus fumigatusprotein farnesyltransferase complexed with substrates and inhibitors reveal features for antifungal drug designPharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plantsThe discovery of a novel compound with potent antitumor activity: virtual screening, synthesis, biological evaluation and preliminary mechanism study.Rapid analysis of protein farnesyltransferase substrate specificity using peptide libraries and isoprenoid diphosphate analogues.Structure-based design and synthesis of potent, ethylenediamine-based, mammalian farnesyltransferase inhibitors as anticancer agentsSynthetic isoprenoid analogues for the study of prenylated proteins: Fluorescent imaging and proteomic applications.Exploring protein lipidation with chemical biology.Prenyltransferase Inhibitors: Treating Human Ailments from Cancer to Parasitic Infections.Virtual lead identification of farnesyltransferase inhibitors based on ligand and structure-based pharmacophore techniques.IADE: a system for intelligent automatic design of bioisosteric analogsBinding mode of conformations and structure-based pharmacophore development for farnesyltransferase inhibitorsCurrent and Future Strategies for Improving Drug Discovery Efficiency
P2860
Q27671538-D8086580-7329-462E-940C-3907AACABB9FQ27680918-F8CDDE0C-2600-4411-9B6A-128DC30DEA93Q28596537-E01D517A-6872-4556-93F6-C1D0DB2E76F7Q33648593-659894DD-E8F2-4356-8DB3-8BC2819421C4Q34061234-32241C7A-BEDE-4994-8DBB-CE20B26F49ACQ34609385-FCC40B0D-121E-4B18-88A5-13870E404AD1Q36515556-89DB8B38-E4AF-4344-9F1D-9F821CA658CCQ37932506-0AA49AD9-59F2-432E-90D0-62C7A9501A42Q38296605-500096A0-6CE4-4EFB-9B43-DB925BA16436Q42922694-51A4407D-9F70-4ED1-B78B-9B0EDDD9FB71Q56918926-1FFA8CED-18F9-4643-AE6F-996BF0BBD57CQ57990897-2890BB8C-8C03-4670-853A-DC9EFC085F70Q58636775-210D6BE4-3790-4E21-A5E8-71A756E9C17E
P2860
Structural Basis for Binding and Selectivity of Antimalarial and Anticancer Ethylenediamine Inhibitors to Protein Farnesyltransferase
description
2009 nî lūn-bûn
@nan
2009 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@ast
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@en
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@nl
type
label
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@ast
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@en
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@nl
prefLabel
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@ast
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@en
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@nl
P2093
P2860
P921
P3181
P1476
Structural Basis for Binding a ...... to Protein Farnesyltransferase
@en
P2093
Andrew D Hamilton
Christopher G Cummings
Erin E Pusateri
Kasey Rivas
Lorena S Beese
Michael A Hast
Michelle A Blaskovich
Said M Sebti
Steven Fletcher
P2860
P304
P3181
P356
10.1016/J.CHEMBIOL.2009.01.014
P577
2009-02-27T00:00:00Z